Kratos Defense Receives a Buy from Noble Financial

By Carrie Williams

Noble Financial analyst Mark Jordan reiterated a Buy rating on Kratos Defense (NASDAQ: KTOS) yesterday and set a price target of $14. The company’s shares closed yesterday at $11.12.

According to TipRanks.com, Jordan is a 3-star analyst with an average return of 8.2% and a 78.6% success rate. Jordan covers the Healthcare sector, focusing on stocks such as ContraVir Pharmaceuticals Inc, Adamas Pharmaceuticals, and Corbus Pharmaceuticals.

Kratos Defense has an analyst consensus of Moderate Buy, with a price target consensus of $12.42.

Based on Kratos Defense’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $186 million and GAAP net loss of $6.2 million. In comparison, last year the company earned revenue of $168 million and had a GAAP net loss of $10.4 million.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Kratos Defense & Security Solutions, Inc. provides mission critical products, services and solutions for United States national security priorities. It operates through the following segments: Kratos Government Solutions, Unmanned Systems, and Public Safety & Security.